Investor Stock List
Ranked #523 of 8,699 institutional investors

Ra Capital Management, L.P.

Boston, MA

$9.25B
US stock portfolio at live prices · today −$93.7M (−1.00%)
Live prices, last trade 11:32 AM ET
Value at quarter end (Q3 2026)
$9.97B
Change from Q2 2026
−$1.54B (−13.37%)
Positions
81 · 16 new, 9 sold out
Filed
Nov 16, 2026

Not counted in the ranking: none$2.76B of holdings we could not match to a US listing are included at their reported quarter-end value.

Holdings

Q3 2026 13F, live prices
PBLS 8.78%RYTM 8.18%PCVX 7.05%EWTX 3.67%COAG 3.34%
StockSharesValue, live% of portfoliovs Q2 2026
PBLS Parabilis Medicines, Inc.29,177,964$813M8.78%Added +1%
RYTM Rhythm Pharmaceuticals, Inc.6,666,837$757M8.18%Unchanged
PCVX Vaxcyte, Inc.11,474,599$653M7.05%Unchanged
EWTX Edgewise Therapeutics, Inc.8,392,730$339M3.67%Unchanged
COAG Hemab Therapeutics Holdings, Inc.7,808,627$309M3.34%Unchanged
SGP SpyGlass Pharma, Inc.8,021,117$246M2.66%Unchanged
TYRA Tyra Biosciences, Inc.12,198,625$246M2.66%Unchanged
SEPN Septerna, Inc.5,502,858$215M2.33%Reduced −21%
IRON Disc Medicine, Inc.2,450,221$183M1.98%Unchanged
XNCR Xencor, Inc.5,274,274$177M1.91%Unchanged
ORKA Oruka Therapeutics, Inc.1,554,597$146M1.58%Unchanged
FRNM Freenome, Inc.15,367,270$145M1.56%New
JANX Janux Therapeutics, Inc.11,189,693$116M1.26%Unchanged
TSHA Taysha Gene Therapies, Inc.30,435,190$114M1.23%Added +29%
AMLX Amylyx Pharmaceuticals, Inc.4,279,341$111M1.20%New
MLYS Mineralys Therapeutics, Inc.7,692,750$108M1.16%Unchanged
CLYM Climb Bio Inc10,130,130$93.3M1.01%Reduced −10%
VOR Vor Biopharma Inc.4,503,882$89.0M0.96%Added +87%
LBRX LB Pharmaceuticals Inc2,208,604$85.9M0.93%Unchanged
SLDB Solid Biosciences Inc.12,036,126$75.9M0.82%Unchanged
PEPG PepGen Inc.20,064,545$74.5M0.81%Unchanged
WVE Wave Life Sciences, Inc.26,975,505$72.7M0.79%Unchanged
ABVX ABIVAX Société Anonyme1,030,058$71.8M0.78%Reduced −9%
ARTV Artiva Biotherapeutics, Inc.18,489,293$71.6M0.77%Added +3%
OBX Obsidian Therapeutics, Inc.5,957,103$71.5M0.77%New
LTGO Latigo Biotherapeutics, Inc.5,302,933$69.4M0.75%New
BCAX Bicara Therapeutics Inc.7,255,993$64.4M0.70%Unchanged
ZLAB Zai Lab Limited2,815,543$58.4M0.63%Reduced −51%
FDMT 4D Molecular Therapeutics, Inc.5,049,779$53.5M0.58%Unchanged
MNPR Monopar Therapeutics Inc.667,207$45.5M0.49%Unchanged
ACRS Aclaris Therapeutics, Inc.12,723,026$44.2M0.48%Unchanged
GERN Geron Corporation42,754,145$38.9M0.42%Reduced −0%
RZLT Rezolute, Inc.9,445,039$37.6M0.41%Unchanged
SPRY ARS Pharmaceuticals, Inc.10,860,977$34.7M0.38%Unchanged
KRSA Korsana Biosciences, Inc.892,743$33.8M0.37%New
DBVT DBV Technologies S.A.3,657,644$33.4M0.36%New
SANA Sana Biotechnology, Inc.18,750,000$30.9M0.33%Unchanged
JBIO Jade Biosciences, Inc.1,835,542$28.0M0.30%Reduced −50%
AGEN Agenus Inc.4,122,000$25.4M0.27%New
EVMN Evommune Inc3,494,638$24.8M0.27%Unchanged
CAPR Capricor Therapeutics, Inc.3,014,183$23.8M0.26%Added +100%
ASMB Assembly Biosciences, Inc.1,020,410$22.7M0.25%Unchanged
SCTX Scribe Therapeutics Inc.1,802,178$21.9M0.24%New
IPSC Century Therapeutics, Inc.17,754,430$21.7M0.23%Unchanged
PRLD Prelude Therapeutics Incorporated6,475,882$20.8M0.22%Unchanged
CCCC C4 Therapeutics, Inc.8,194,779$20.4M0.22%Added +2%
QTTB Q32 Bio Inc.2,332,457$19.7M0.21%Unchanged
SION Sionna Therapeutics, Inc.6,456,234$18.5M0.20%Reduced −35%
AURA Aura Biosciences, Inc.2,500,000$17.1M0.19%Unchanged
SGMT Sagimet Biosciences Inc.1,800,000$16.3M0.18%New
LXEO Lexeo Therapeutics, Inc.5,000,000$15.9M0.17%Unchanged
MIRM Mirum Pharmaceuticals, Inc.159,278$15.6M0.17%Reduced −50%
EDIT Editas Medicine, Inc.8,889,000$15.3M0.17%Unchanged
ACRV Acrivon Therapeutics, Inc.12,229,396$15.1M0.16%Unchanged
BNTC Benitec Biopharma Inc.1,850,000$14.7M0.16%Unchanged
ETRA Electra Therapeutics, Inc.1,692,965$14.6M0.16%New
ALXO ALX Oncology Holdings Inc.13,011,849$14.0M0.15%Unchanged
LENZ LENZ Therapeutics, Inc.4,178,823$13.1M0.14%Unchanged
SPTX Seaport Therapeutics, Inc.700,000$12.9M0.14%Unchanged
NKTX Nkarta, Inc.10,805,129$12.6M0.14%Unchanged
INO Inovio Pharmaceuticals, Inc.7,220,384$12.5M0.14%New
OVID Ovid Therapeutics Inc.5,598,200$12.4M0.13%Reduced −47%
AVR Anteris Technologies Global Corp.2,474,076$12.3M0.13%Reduced −18%
SABS SAB Biotherapeutics, Inc.4,401,500$12.2M0.13%Unchanged
BRVE Braveheart Bio, Inc.565,000$11.3M0.12%New
OKUR OnKure Therapeutics, Inc.3,998,333$11.0M0.12%Unchanged
IKT Inhibikase Therapeutics, Inc.6,970,000$9.1M<0.1%New
ALT Altimmune, Inc.6,500,000$8.9M<0.1%Unchanged
AVTX Avalo Therapeutics, Inc.1,000,000$6.8M<0.1%Unchanged
PALI Palisade Bio, Inc.7,124,116$6.6M<0.1%Unchanged
DRUG Bright Minds Biosciences Inc.265,000$5.6M<0.1%Unchanged
RANI Rani Therapeutics Holdings, Inc.8,500,000$4.8M<0.1%Unchanged
CRBP Corbus Pharmaceuticals Holdings, Inc.1,914,788$4.3M<0.1%New
MGNX MacroGenics, Inc.1,864,176$3.8M<0.1%Unchanged
ABOS Acumen Pharmaceuticals, Inc.20,992,669$3.6M<0.1%Unchanged
EQ Equillium, Inc.2,317,741$2.7M<0.1%Reduced −25%
ACET Adicet Bio, Inc.932,624$2.3M<0.1%Unchanged
STOK Stoke Therapeutics, Inc.73,607$2.0M<0.1%New
STRO Sutro Biopharma, Inc.210,934$1.9M<0.1%New
FTH Faeth Therapeutics, Inc.205,060$1.8M<0.1%Reduced −72%
PTN Palatin Technologies, Inc.62,124$309K<0.1%Unchanged

Sold out in Q3 2026

StockShares held at Q2 2026Worth today
BCRX BioCryst Pharmaceuticals, Inc.15,827,186$116M
NTLA Intellia Therapeutics, Inc.4,526,926$46.0M
DFTX Definium Therapeutics, Inc.1,500,000$43.7M
AKTS Aktis Oncology, Inc.1,314,405$21.6M
WAY Waystar Holding Corp.529,400$14.2M
BIOA BioAge Labs, Inc.1,671,648$7.5M
CRVS Corvus Pharmaceuticals, Inc.450,000$4.4M
HOWL Werewolf Therapeutics, Inc.2,387,744$2.2M
KPTIQ Karyopharm Therapeutics Inc.1,917,354$65K